SGXP Sgx Pharmaceuticals (MM)

SAN DIEGO, Feb. 6 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals, Inc. (NASDAQ:SGXP) announced today that the Company will be presenting at two upcoming investor conferences. The conference information is as follows: -- 10th Annual BIO CEO & Investor Conference: Wednesday, February 13, 2008 at 1:15 PM Eastern Standard Time at the Waldorf=Astoria, New York City. -- Roth 20th Annual OC Growth Stock Conference: Tuesday, February 19, 2008 at 11:30 AM Pacific Standard Time at the Ritz Carlton Laguna Niguel, California. A live webcast of both presentations will be available under the investor relations section of the Company's website at http://www.sgxpharma.com/. Replays of the presentation will be available for 90 days following the event. Please connect to the Company's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary. About SGX Pharmaceuticals SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The SGX oncology pipeline includes drug candidates from its FAST(TM) drug discovery platform, such as SGX523, a cMET kinase inhibitor currently in Phase 1 clinical studies, next generation BCR-ABL inhibitors being developed by SGX and in partnership with Novartis, and JAK2 inhibitors. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com/ and in the Company's various filings with the Securities and Exchange Commission. DATASOURCE: SGX Pharmaceuticals, Inc. CONTACT: Bonnie Feldman, Sr. Director, Investor Relations of SGX Pharmaceuticals, Inc., +1-858-344-8860 Web site: http://www.sgxpharma.com/

Copyright